William Walsh to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications William Walsh has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.083
-
Piperdi B, Walsh WV, Bradley K, Zhou Z, Bathini V, Hanrahan-Boshes M, Hutchinson L, Perez-Soler R. Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer. J Thorac Oncol. 2012 Jun; 7(6):1032-40.
Score: 0.083